155 related articles for article (PubMed ID: 28322096)
1. CDX2 immunostaining in primary and metastatic germ cell tumours of the testis.
Oz Atalay F; Aytac Vuruskan B; Vuruskan H
J Int Med Res; 2016 Dec; 44(6):1323-1330. PubMed ID: 28322096
[TBL] [Abstract][Full Text] [Related]
2. [Fundamentals in the pathology of testicular germ cell tumours].
Fichtner A; Bremmer F
Pathologie (Heidelb); 2023 Nov; 44(6):401-413. PubMed ID: 37737316
[TBL] [Abstract][Full Text] [Related]
3. Testicular germ cell tumour cells release microRNA-containing extracellular vesicles that induce phenotypic and genotypic changes in cells of the tumour microenvironment.
Alonso-Crisostomo L; Trendell J; Ferraresso M; Bailey S; Ward D; Scurlock ZGL; Wenlock SC; Bastos CAP; Jugdaohsingh R; Faria NJ; Enright AJ; Scarpini CG; Coleman N; Murray MJ
Int J Cancer; 2024 Jan; 154(2):372-388. PubMed ID: 37632231
[TBL] [Abstract][Full Text] [Related]
4. Testicular Mixed Teratoma and Yolk Sac Tumor, Prepubertal Type: A Case Report with Summary of Prior Published Cases.
Mohin M; Dey S; Ray R; Wasim Sk F; Das O; Chatterjee U
Fetal Pediatr Pathol; 2024; 43(2):182-187. PubMed ID: 37946365
[TBL] [Abstract][Full Text] [Related]
5. Histopathological Analysis in Testicular Tumors: 10 Years of Experience.
Kılınç F; Tas Ayçiçek S; Esen HH
Int J Surg Pathol; 2024 Apr; 32(2):331-339. PubMed ID: 37292006
[No Abstract] [Full Text] [Related]
6. Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence.
Xu L; Pierce JL; Sanchez A; Chen KS; Shukla AA; Fustino NJ; Stuart SH; Bagrodia A; Xiao X; Guo L; Krailo MD; Shaikh F; Billmire DF; Pashankar F; Bestrashniy J; Oosterhuis JW; Gillis AJM; Xie Y; Teot L; Mora J; Poynter JN; Rakheja D; Looijenga LHJ; Draper BW; Frazier AL; Amatruda JF
Nat Commun; 2023 May; 14(1):2636. PubMed ID: 37149691
[TBL] [Abstract][Full Text] [Related]
7. Frequent Fas gene mutations in testicular germ cell tumors.
Takayama H; Takakuwa T; Tsujimoto Y; Tani Y; Nonomura N; Okuyama A; Nagata S; Aozasa K
Am J Pathol; 2002 Aug; 161(2):635-41. PubMed ID: 12163388
[TBL] [Abstract][Full Text] [Related]
8. Application of microRNAs in the diagnosis and monitoring of pediatric germ cell tumors: Kazakh experience.
Saliyeva S; Boranbayeva R; Bulegenova M; Beloussov V
Pediatr Hematol Oncol; 2024; 41(2):121-134. PubMed ID: 37898912
[TBL] [Abstract][Full Text] [Related]
9. Ovarian germ cell tumour classification: views from the testis.
Berney DM; Stoneham S; Arora R; Shamash J; Lockley M
Histopathology; 2020 Jan; 76(1):25-36. PubMed ID: 31846529
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge.
Yodkhunnatham N; Pandit K; Puri D; Yuen KL; Bagrodia A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396829
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of SerpinB9 in non-seminomatous germ cell tumors.
Anami T; Ibe Y; Li L; Komohara Y; Hirao H; Harada M; Yano H; Fujiwara Y; Motoshima T; Yatsuda J; Hibi T; Kamba T
Med Mol Morphol; 2024 Mar; 57(1):68-75. PubMed ID: 37991604
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis.
Bilen MA; Hess KR; Campbell MT; Wang J; Broaddus RR; Karam JA; Ward JF; Wood CG; Choi SL; Rao P; Zhang M; Naing A; General R; Cauley DH; Lin SH; Logothetis CJ; Pisters LL; Tu SM
Oncotarget; 2016 Dec; 7(52):86280-86289. PubMed ID: 27861143
[TBL] [Abstract][Full Text] [Related]
13. An introduction to the WHO 5th edition 2022 classification of testicular tumours.
Berney DM; Cree I; Rao V; Moch H; Srigley JR; Tsuzuki T; Amin MB; Comperat EM; Hartmann A; Menon S; Netto GJ; Rubin MA; Turajlic S; Raspollini MR; Tickoo SK
Histopathology; 2022 Oct; 81(4):459-466. PubMed ID: 35502823
[TBL] [Abstract][Full Text] [Related]
14. Malignant ovarian and testicular germ cell tumors: Common characteristics but different prognoses.
Sköld C; Jansson AK; Glimelius I
J Intern Med; 2024 Jun; 295(6):715-734. PubMed ID: 38468475
[TBL] [Abstract][Full Text] [Related]
15. BMP Inhibition in Seminomas Initiates Acquisition of Pluripotency via NODAL Signaling Resulting in Reprogramming to an Embryonal Carcinoma.
Nettersheim D; Jostes S; Sharma R; Schneider S; Hofmann A; Ferreira HJ; Hoffmann P; Kristiansen G; Esteller MB; Schorle H
PLoS Genet; 2015 Jul; 11(7):e1005415. PubMed ID: 26226633
[TBL] [Abstract][Full Text] [Related]
16. Testicular cancer: new developments, molecular pathology, and current research keynote.
Lopez-Beltran A
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):204-207. PubMed ID: 37975918
[TBL] [Abstract][Full Text] [Related]
17. [Fundamentals in the pathology of testicular tumours].
Fichtner A; Bremmer F
Pathologie (Heidelb); 2024 Feb; 45(1):71-82. PubMed ID: 38265500
[TBL] [Abstract][Full Text] [Related]
18. Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption.
Bailey S; Ferraresso M; Alonso-Crisostomo L; Ward D; Smith S; Nicholson JC; Saini H; Enright AJ; Scarpini CG; Coleman N; Murray MJ
Br J Cancer; 2023 Oct; 129(9):1451-1461. PubMed ID: 37789102
[TBL] [Abstract][Full Text] [Related]
19. New analysis of atypical spermatocytic tumours reveals extensive heterogeneity and plasticity of germ cell tumours
Rajpert-De Meyts E; Goriely A; Almstrup K
J Pathol; 2024 May; 263(1):1-4. PubMed ID: 38362619
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
